RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Schmidt LJ, Duncan K, Yadav N, Regan KM, Verone AR, Lohse CM, Pop EA, Attwood K, Wilding G, Mohler JL, Sebo TJ, Tindall DJ, Heemers HV.
Schmidt LJ, et al. Among authors: attwood k.
Mol Endocrinol. 2012 May;26(5):716-35. doi: 10.1210/me.2011-1130. Epub 2012 Mar 28.
Mol Endocrinol. 2012.
PMID: 22456196
Free PMC article.